240 filings
Page 3 of 12
8-K
3wgtkd7cw 6dlk9g
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
n8058ksv5j1udjijwy
9 Sep 22
Departure of Directors or Certain Officers
4:49pm
8-K
gsup6f2aqqut
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
p70h8
1 Aug 22
Other Events
7:11am
8-K
k08x65hbpfl0m ttf
31 May 22
Submission of Matters to a Vote of Security Holders
5:00pm
SD
yx219s
23 May 22
Conflict minerals disclosure
4:50pm
8-K
2jcpjz3xjecfcr ik
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
DEFA14A
etfe28o
11 Apr 22
Additional proxy soliciting materials
4:50pm
S-8
1d7hjuf5
23 Feb 22
Registration of securities for employees
5:09pm
8-K
ooyv uxfxxbt
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
iyk5rv
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am
8-K
4w5xmpy gk
8 Nov 21
Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
4:18pm
8-K
v27xfx9 alrdlmcqtb
31 Aug 21
Nevro Announces Director Appointment
4:17pm